These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
    Author: Dinh HV, McCormack C, Hall S, Prince HM.
    Journal: J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377.
    Abstract:
    Three patients suffering from classic dermatomyositis (juvenile and adult-onset) with prominent recalcitrant skin manifestations are described. All patients demonstrated good control of muscle symptoms on immunosuppressive medications, but their cutaneous disease persisted despite treatment with at least 4 different systemic treatments and topical agents. They were given rituximab, a monoclonal anti-CD20 antibody, achieving a response with minimal side effects. We document our experience with this medication for the cutaneous lesions of dermatomyositis.
    [Abstract] [Full Text] [Related] [New Search]